Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders
- PMID: 22028219
- PMCID: PMC3203752
- DOI: 10.1002/ana.22615
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders
Abstract
The misfolding and aggregation of specific proteins is a seminal occurrence in a remarkable variety of neurodegenerative disorders. In Alzheimer disease (the most prevalent cerebral proteopathy), the two principal aggregating proteins are β-amyloid (Aβ) and tau. The abnormal assemblies formed by conformational variants of these proteins range in size from small oligomers to the characteristic lesions that are visible by optical microscopy, such as senile plaques and neurofibrillary tangles. Pathologic similarities with prion disease suggest that the formation and spread of these proteinaceous lesions might involve a common molecular mechanism-corruptive protein templating. Experimentally, cerebral β-amyloidosis can be exogenously induced by exposure to dilute brain extracts containing aggregated Aβ seeds. The amyloid-inducing agent probably is Aβ itself, in a conformation generated most effectively in the living brain. Once initiated, Aβ lesions proliferate within and among brain regions. The induction process is governed by the structural and biochemical nature of the Aβ seed, as well as the attributes of the host, reminiscent of pathogenically variant prion strains. The concept of prionlike induction and spreading of pathogenic proteins recently has been expanded to include aggregates of tau, α-synuclein, huntingtin, superoxide dismutase-1, and TDP-43, which characterize such human neurodegenerative disorders as frontotemporal lobar degeneration, Parkinson/Lewy body disease, Huntington disease, and amyotrophic lateral sclerosis. Our recent finding that the most effective Aβ seeds are small and soluble intensifies the search in bodily fluids for misfolded protein seeds that are upstream in the proteopathic cascade, and thus could serve as predictive diagnostics and the targets of early, mechanism-based interventions. Establishing the clinical implications of corruptive protein templating will require further mechanistic and epidemiologic investigations. However, the theory that many chronic neurodegenerative diseases can originate and progress via the seeded corruption of misfolded proteins has the potential to unify experimental and translational approaches to these increasingly prevalent disorders.
Copyright © 2011 American Neurological Association.
Figures
Similar articles
-
Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases.Annu Rev Genet. 2016 Nov 23;50:329-346. doi: 10.1146/annurev-genet-120215-034943. Annu Rev Genet. 2016. PMID: 27893962 Free PMC article. Review.
-
Aβ seeds and prions: How close the fit?Prion. 2017 Jul 4;11(4):215-225. doi: 10.1080/19336896.2017.1334029. Epub 2017 Jun 28. Prion. 2017. PMID: 28657440 Free PMC article.
-
Prion-like mechanisms in Alzheimer disease.Handb Clin Neurol. 2018;153:303-319. doi: 10.1016/B978-0-444-63945-5.00016-7. Handb Clin Neurol. 2018. PMID: 29887142 Free PMC article. Review.
-
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.Nature. 2013 Sep 5;501(7465):45-51. doi: 10.1038/nature12481. Nature. 2013. PMID: 24005412 Free PMC article. Review.
-
Antibody 9D5 recognizes oligomeric pyroglutamate amyloid-β in a fraction of amyloid-β deposits in Alzheimer's disease without cross-reactivity with other protein aggregates.J Alzheimers Dis. 2012;29(2):361-71. doi: 10.3233/JAD-2011-111379. J Alzheimers Dis. 2012. PMID: 22232007
Cited by 228 articles
-
Aggregation and Prion-Inducing Properties of the G-Protein Gamma Subunit Ste18 are Regulated by Membrane Association.Int J Mol Sci. 2020 Jul 16;21(14):5038. doi: 10.3390/ijms21145038. Int J Mol Sci. 2020. PMID: 32708832 Free PMC article.
-
Passive immunotherapies targeting Aβ and tau in Alzheimer's disease.Neurobiol Dis. 2020 Jul 16:105010. doi: 10.1016/j.nbd.2020.105010. Online ahead of print. Neurobiol Dis. 2020. PMID: 32682954 Free PMC article. Review.
-
Testing Amyloid Cross-Toxicity in the Vertebrate Brain.ACS Omega. 2020 Jun 15;5(25):15586-15591. doi: 10.1021/acsomega.0c01819. eCollection 2020 Jun 30. ACS Omega. 2020. PMID: 32637834 Free PMC article.
-
HspB5 Activates a Neuroprotective Glial Cell Response in Experimental Tauopathy.Front Neurosci. 2020 Jun 11;14:574. doi: 10.3389/fnins.2020.00574. eCollection 2020. Front Neurosci. 2020. PMID: 32595446 Free PMC article.
-
Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's Disease.Mol Neurobiol. 2020 Aug;57(8):3258-3272. doi: 10.1007/s12035-020-01950-1. Epub 2020 Jun 8. Mol Neurobiol. 2020. PMID: 32514860 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical